CD226 and cancer: At baseline, expression of DNAM-1 and NKG2D was more variable on cancer patient Vγ9Vδ2 T-cells and expression did not significantly change upon expansion with the TAA-Vδ2hi-lo bsVHH and bsVHH-Fc molecules.